top of page

HUMAN MEDICAL

PRODUCT

See Factor CT3™

2021-Product-Line-Up-with-Logos-seefactorct3.png

Epica’s all new See Factor CT3™ , a High Resolution, Mobile, Multi-Modality Point-of-Care Imaging Platform is designed to deliver non-interpolated, isotropic volumetric DICOM data.  SeeFactorCT3™ offers high spatial resolution and low noise in its CT images that can be displayed within minutes of acquisition in the onboard DICOM viewer.

New FDA 510(k) Approval

Epica International, an established innovator in advanced imaging solutions and industrial robotics, is proud to announce that its See Factor CT3™ System has received an updated 510(k) clearance from the U.S. Food and Drug Administration (FDA).

This clearance marks a significant milestone in the company’s mission to bring high resolution CT imaging to human point-of-care applications such as the operating room. The update addresses numerous changes made to the device since its original clearance and release in 2019 and allows Epica International to market and distribute the new functionality See Factor CT3™ across the United States. 

bottom of page